Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20067037 | 0.88 | BLM (0.35) | BLMPMP22HSD17B10ALDH1A1 | |
| SCHEMBL12120246 | 0.80 | DNM1 (0.48) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL16865883 | 0.80 | DNM1 (0.38) | DNM1DGKABLMPMP22HSD17B10 | |
| SCHEMBL889222 | 0.79 | DNM1 (0.47) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL889158 | 0.77 | DNM1 (0.46) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL10363051 | 0.77 | DGKA (0.45) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL14182311 | 0.76 | DNM1 (0.42) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL14182351 | 0.76 | DNM1 (0.42) | DNM1DGKABLMALDH1A1GLA | |
| SCHEMBL889193 | 0.76 | DNM1 (0.49) | DNM1DGKABLMALDH1A1 | |
| SCHEMBL20067045 | 0.75 | MEN1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180108944-A1 | GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108944-A1 | GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE | ILK, GK, KCNH3 | DNM1 2065/4885DGKA 133/4885BLM 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.